Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CPA3 |
| Upstream (Parents) |
|---|
| (<<) TPSB2///TPSAB1 → CPA3 |
| (<<) TPSB2 → CPA3 |
| (<<) MMP2 → CPA3 |
| (<<) RAB31 → CPA3 |
| Downstream (Children) |
|---|
| CPA3 → HLA-DRB4 (>>) |
| CPA3 → TPSAB1 (>>) |
| CPA3 → TPSB2///TPSAB1 (>>) |
| CPA3 → ZBED2 (>>) |
| CPA3 → TPSB2 (>>) |
| CPA3 → DLK1 (>>) |
| CPA3 → ACHE (>>) |
| CPA3 → NLRP1 (>>) |
| CPA3 → MCTP1 (>>) |
| CPA3 → AMOT (>>) |
| CPA3 → LMO3 (>>) |
| CPA3 → GDAP1L1 (>>) |
